Stay updated on ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial
Sign up to get notified when there's something new on the ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial page.

Latest updates to the ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now shows Revision: v3.3.2, replacing the previous v3.3.1. This appears to be a minor system update with no changes to the study details or functionality.SummaryDifference0.0%

- Check21 days agoChange DetectedAdded a PubMed auto-fill notice in Publications and updated the Revision to v3.3.1; the previous PubMed wording and Revision: v3.2.0 were removed.SummaryDifference0.1%

- Check29 days agoChange DetectedThe funding-status notice banner about government funding lapse has been removed from the page.SummaryDifference0.3%

- Check43 days agoChange DetectedThe updates shown in the screenshots are limited to the last update timestamp and minor text edits. There are no changes to the primary study information, such as design, endpoints, eligibility criteria, or participating sites.SummaryDifference0.4%

- Check72 days agoChange Detected- Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference2%

- Check79 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ICON: Immunogenic Chemo + Ipilimumab/Nivolumab Clinical Trial page.